A study on Financial Indicators of selected Pharmaceutical Companies

Authors

  • Rathod Vishal Mayabhai Research Scholar, Saurashtra University Rajkot, India
  • N. D. Zala Associate Professor, M. B. Arts and Commerce College, Gondal, Rajkot, India

DOI:

https://doi.org/10.56209/jommerce.v2i2.16

Keywords:

Financial Indicators, Independent T-Test, Net Profit Margin Ratio, Return on Assets Ratio, Current Ratio, Quick Ratio

Abstract

The aim of this study is to analyses financial ratios. This study covers four different ratios; net profit margin ratio, return on assets ratio, current ratio and quick ratio as financial indicators. This study is based on secondary data and data are collected from moneycontrol.com. Researcher has selected two pharmaceuticals’ companies by using simple random sampling. Independent t-test has been used as a statistical tool and findings were discussed.

References

Abdulkareem, A. M. (2020). Financial Performance of Indian Pharmaceutical Companies: Analysis of Leverage and Cost of Capital. Journal of Advanced Research in Economics and Administrative Sciences, 1(1), 13-22. https://doi.org/10.47631/jareas.v1i1.15

Selvam, M. (2020). Impact of convergence with IFRS on selected pharmaceuticals companies in India. Pavithran, A., Selvam, M., Miencha, IO, Jayapal, G., Kathiravan, C.(2020). Impact of convergence with IFRS on selected pharmaceuticals companies in India. Journal of Advanced Research in Dynamical and Control Systems, 12(4), 183-191. Jour of Adv Research in Dynamical & Control Systems, Vol. 12, 04-Special Issue, 2020. https://doi.org/10.5373/JARDCS/V12SP4/20201480

Ahamed, M. J. (2020). Comparison of the Financial Performance between Square Pharmaceuticals Limited and Beximco Pharmaceuticals Limited: DuPont Analysis. Global Disclosure of Economics and Business, 9(1), 39-48. https://doi.org/10.18034/gdeb.v9i1.506

Prasad, P., Bajracharya, S. R., Deo, S., Lamichhane, S., Pradhan, P. M. S., Ghimire, R., & Pokharel, A. (2019). Adherence of drug promotional literatures distributed by pharmaceutical companies to World Health Organization ethical criteria for medicinal drug promotion. Journal of Nepal Health Research Council, 17(3), 345-350. https://doi.org/10.33314/jnhrc.v17i3.1840

Kimbowa, I. M., Eriksen, J., Nakafeero, M., Obua, C., Lundborg, C. S., Kalyango, J., & Ocan, M. (2022). Antimicrobial stewardship: Attitudes and practices of healthcare providers in selected health facilities in Uganda. PloS one, 17(2), e0262993. https://doi.org/10.1371/journal.pone.0262993

Cha, Y., Erez, T., Reynolds, I. J., Kumar, D., Ross, J., Koytiger, G., ... & Laifenfeld, D. (2018). Drug repurposing from the perspective of pharmaceutical companies. British journal of pharmacology, 175(2), 168-180. https://doi.org/10.1111/bph.13798

Brax, H., Fadlallah, R., Al-Khaled, L., Kahale, L. A., Nas, H., El-Jardali, F., & Akl, E. A. (2017). Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PloS one, 12(4), e0175493. https://doi.org/10.1371/journal.pone.0175493

McWilliams, J. C., Allian, A. D., Opalka, S. M., May, S. A., Journet, M., & Braden, T. M. (2018). The evolving state of continuous processing in pharmaceutical API manufacturing: a survey of pharmaceutical companies and contract manufacturing organizations. Organic Process Research & Development, 22(9), 1143-1166. https://doi.org/10.1021/acs.oprd.8b00160

Downloads

Published

2022-06-30